catechin has been researched along with Epstein-Barr Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bode, AM; Cao, Y; Dong, Z; Hu, J; Li, H; Li, Y; Liao, W; Liu, S; Liu, X; Luo, X; Tang, M | 1 |
| Bode, AM; Cao, Y; Chen, L; Dong, Z; Li, H; Li, L; Li, W; Li, Z; Liu, H; Liu, S; Tang, M; Tao, Y; Yang, L | 1 |
2 other study(ies) available for catechin and Epstein-Barr Virus Infections
| Article | Year |
|---|---|
()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes.
Topics: Antiviral Agents; Catechin; Cell Line, Tumor; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Mutation; Phosphorylation; Promoter Regions, Genetic; Tumor Suppressor Protein p53; Viral Matrix Proteins; Virus Replication | 2021 |
(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells.
Topics: Antiviral Agents; Catechin; Cell Line, Tumor; Cell Survival; Chromones; DNA, Viral; Enzyme Activation; Epstein-Barr Virus Infections; Flavonoids; Herpesvirus 4, Human; Humans; Lymphoma; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Morpholines; Nasopharyngeal Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Viral Proteins; Virus Activation | 2013 |